A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Part of paid clinical trials in Bellingham, Washington.

Sponsor
Fred Hutchinson Cancer Center
Study ID
NCT06771739
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Electronic Health Record Review — OTHER
    Ancillary studies
  • Interview — OTHER
    Ancillary studies
  • Support — OTHER
    Receive $1000 preloaded cash card
  • Support — OTHER
    Receive $100 preloaded cash card
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Key Dates

Start date
Jul 1, 2026
Status verified
May 2026
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Arm A (high payment schedule)
    Patients receive a $1000 preloaded cash card once monthly for 3 months.
  • Active Comparator: Arm B (low payment schedule)
    Patients receive a $100 preloaded cash card once monthly for 3 months.

Primary Outcome Measure

Participant enrollment [ Time Frame: Up to 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
PeaceHealth Saint Joseph Medical CenterBellinghamWashington98225
Rebecca Crompton (PRINCIPAL_INVESTIGATOR)
PeaceHealth Southwest Medical CenterVancouverWashington98664
Rebecca Crompton (PRINCIPAL_INVESTIGATOR)

Find similar trials in Bellingham, WA

By research site
PeaceHealth Saint Joseph Medical Center· Bellingham, WAPeaceHealth Southwest Medical Center· Vancouver, WA

Related Studies